Philip A. Barker mostly deals with Cell biology, Low-affinity nerve growth factor receptor, Neuroscience, Receptor and Programmed cell death. His study in Cell biology is interdisciplinary in nature, drawing from both Inhibitor of apoptosis, Cancer research and Ubiquitin. He interconnects Tropomyosin receptor kinase A and Trk receptor in the investigation of issues within Low-affinity nerve growth factor receptor.
His study looks at the relationship between Trk receptor and topics such as Tropomyosin receptor kinase B, which overlap with Brain-derived neurotrophic factor. His Neuroscience study combines topics in areas such as Tumor necrosis factor alpha, Genetically modified mouse and Signal transduction. His Programmed cell death research integrates issues from Cell survival and Growth inhibition.
His main research concerns Cell biology, Neuroscience, Low-affinity nerve growth factor receptor, Oceanography and Diatom. The concepts of his Cell biology study are interwoven with issues in Apoptosis, Cancer research and Neurotrophic factors. The Low-affinity nerve growth factor receptor study which covers Tropomyosin receptor kinase A that intersects with Receptor tyrosine kinase and Endocrinology.
His Oceanography study combines topics from a wide range of disciplines, such as δ18O and Quaternary. His Diatom research includes elements of Environmental chemistry, Tropics, Sediment and Isotopes of oxygen. As a part of the same scientific study, Philip A. Barker usually deals with the Nerve growth factor, concentrating on Molecular biology and frequently concerns with Gene.
The scientist’s investigation covers issues in Neuroscience, Cell biology, Diatom, Oceanography and Synapse. His Neuroscience research is multidisciplinary, incorporating perspectives in Synaptic plasticity, Neurotrophin and Nerve growth factor. In the subject of general Neurotrophin, his work in Tropomyosin receptor kinase A is often linked to Calpain, thereby combining diverse domains of study.
The Cell biology study combines topics in areas such as Apoptosis and Endocytosis. His Diatom research incorporates elements of Trophic level, Sediment and Ecosystem, Carbon cycle. Philip A. Barker works in the field of Receptor, focusing on Low-affinity nerve growth factor receptor in particular.
Philip A. Barker focuses on Neuroscience, Neurotrophin, Cell biology, Tropomyosin receptor kinase B and Brain-derived neurotrophic factor. His Neuroscience study incorporates themes from Glutamate receptor, Apoptosis and Metaplasticity. As a part of the same scientific family, Philip A. Barker mostly works in the field of Neurotrophin, focusing on Neurotrophin-3 and, on occasion, Low-affinity nerve growth factor receptor, Trk receptor and Tropomyosin receptor kinase A.
His study brings together the fields of Cancer research and Low-affinity nerve growth factor receptor. His work carried out in the field of Cell biology brings together such families of science as Neuroplasticity, Microglia and Cytoskeleton. His Tropomyosin receptor kinase B study integrates concerns from other disciplines, such as Endocrinology and Epilepsy.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
cIAP1 and cIAP2 Facilitate Cancer Cell Survival by Functioning as E3 Ligases that Promote RIP1 Ubiquitination
Mathieu J.M. Bertrand;Snezana Milutinovic;Kathleen M. Dickson;Wai Chi Ho.
Molecular Cell (2008)
Neurotrophin signaling through the p75 neurotrophin receptor.
Philippe P Roux;Philip A Barker.
Progress in Neurobiology (2002)
Disruption of NGF binding to the low affinity neurotrophin receptor p75LNTR reduces NGF binding to TrkA on PC12 cells.
Philip A. Barker;Eric M. Shooter.
Multiple Sclerosis: Fas Signaling in Oligodendrocyte Cell Death
Sameer D. D'Souza;Bruno Bonetti;Vijayabalan Balasingam;Neil R. Cashman.
Journal of Experimental Medicine (1996)
Impact of lower atmospheric carbon dioxide on tropical mountain ecosystems
F. Alayne Street-Perrott;Yongsong Huang;R. Alan Perrott;Geoffrey Eglinton.
Detection of brain-derived neurotrophic factor-like activity in fibroblasts and Schwann cells: inhibition by antibodies to NGF.
Ann Acheson;Philip A. Barker;Ralph F. Alderson;Freda D. Miller.
Constitutive Nuclear Factor-κB Activity Is Required for Central Neuron Survival
Asha L. Bhakar;Laura-Lee Tannis;Christine Zeindler;Maria Pia Russo.
The Journal of Neuroscience (2002)
De novo mutations in the gene encoding the synaptic scaffolding protein SHANK3 in patients ascertained for schizophrenia
Julie Gauthier;Nathalie Champagne;Ronald G. Lafrenière;Lan Xiong.
Proceedings of the National Academy of Sciences of the United States of America (2010)
NRAGE, a novel MAGE protein, interacts with the p75 neurotrophin receptor and facilitates nerve growth factor-dependent apoptosis.
Amir H Salehi;Philippe P Roux;Chris J Kubu;Christine Zeindler.
The MAGE proteins: emerging roles in cell cycle progression, apoptosis, and neurogenetic disease.
Philip A. Barker;Amir Salehi.
Journal of Neuroscience Research (2002)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: